Free Protein S Test in Lahore Pakistan at Chughtai Lab

Free Protein S at Chughtai Lab

Protein S is an essential, vitamin K-dependent plasma glycoprotein synthesized primarily in the hepatocytes of the liver, as well as in endothelial cells and megakaryocytes. It plays a critical regulatory role in the human coagulation cascade, acting as a non-enzymatic cofactor to activated Protein C (APC). Together, the APC-Protein S complex selectively cleaves and inactivates activated clotting factors Va and VIIIa, which are crucial rate-limiting steps in thrombin generation. By downregulating these factors, Protein S helps maintain the delicate physiological balance between thrombosis (clot formation) and fibrinolysis (clot dissolution).

In human plasma, Protein S exists in two distinct forms: a free, active form and a bound, inactive form. Approximately 60% to 70% of total plasma Protein S is reversibly bound to C4b-binding protein (C4bBP), a regulatory component of the classical complement pathway. The remaining 30% to 40% circulates as Free Protein S, which is the only form capable of binding to activated Protein C to exert its anticoagulant cofactor activity. Consequently, measuring the concentration of Free Protein S is clinically superior and highly sensitive for diagnosing hereditary or acquired Protein S deficiencies, which significantly elevate a patient’s risk for venous thromboembolism (VTE).

The Free Protein S test at Chughtai Lab is a specialized immunological assay designed to quantify the level of free, functional Protein S antigen in a patient’s blood. This test is a cornerstone of thrombophilia screening profiles, helping clinicians identify underlying hypercoagulable states, manage recurrent thrombotic events, and guide long-term anticoagulation strategies.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is paramount to ensure the clinical validity of the Free Protein S test, as several physiological states, medications, and clinical conditions can profoundly alter circulating protein levels.

• Anticoagulant Therapy Discontinuation: The most critical preparation involves the temporary cessation of oral anticoagulant therapy. Vitamin K antagonists, such as warfarin, significantly reduce the synthesis of functional Protein S, leading to falsely low results. Patients must stop warfarin therapy for at least 2 weeks prior to testing, under the strict supervision of their prescribing physician. Direct oral anticoagulants (DOACs) like rivaroxaban, apixaban, or dabigatran, as well as unfractionated or low-molecular-weight heparin, should also be discontinued for an appropriate period (typically 48 to 72 hours) before sample collection, as they can interfere with functional assays.
• Timing Relative to Thrombotic Events: Testing should not be performed during an acute thrombotic episode or within 3 to 6 months of a deep vein thrombosis (DVT) or pulmonary embolism (PE). During an acute clot, consumption of coagulation factors and regulatory proteins occurs, which can temporarily deplete Free Protein S levels, leading to a false-positive diagnosis of hereditary deficiency.
• Pregnancy and Estrogen Considerations: Pregnancy naturally induces a state of hypercoagulability, which includes a physiological decline in Free Protein S levels. Similarly, oral contraceptive pills (OCPs) and hormone replacement therapy (HRT) can lower Free Protein S. Testing should ideally be deferred until at least 6 weeks postpartum or after discontinuing estrogen-containing medications.
• Fasting and General Preparation: While strict fasting is not universally mandatory for a standalone Free Protein S test, an 8 to 12-hour fast is highly recommended. This prevents lipemia (excess fats in the blood), which can interfere with the optical detection systems used in automated coagulation analyzers. Patients should remain well-hydrated with water.

During the Procedure

The Free Protein S test is performed on a venous blood sample, collected via a standard venipuncture procedure.

• Sample Collection: A trained phlebotomist at Chughtai Lab will locate a suitable vein, typically in the antecubital fossa (the crook of the elbow). The area is thoroughly cleansed with an antiseptic solution. A sterile needle is inserted into the vein, and blood is drawn into a specialized light blue-top tube containing 3.2% buffered sodium citrate. The citrate acts as an anticoagulant by chelating calcium, preserving the plasma proteins and coagulation factors in an inactive state until testing.
• Tube Filling and Mixing: It is clinically vital that the collection tube is filled to its designated capacity to maintain the precise 9:1 blood-to-anticoagulant ratio. Underfilling or overfilling can alter the concentration of citrate, leading to inaccurate test results. Immediately after collection, the tube is gently inverted 3 to 4 times to ensure thorough mixing of the blood with the sodium citrate.
• Processing and Safety: The procedure is quick, taking less than five minutes, and carries minimal risk, limited to mild bruising or transient discomfort at the needle insertion site. Once collected, the sample is promptly centrifuged to separate the platelet-poor plasma, which is then analyzed using advanced immunoturbidimetric or enzyme-linked immunosorbent assays (ELISA) to measure Free Protein S antigen levels.

When is a Free Protein S Test Performed?

Investigation of Unexplained Venous Thromboembolism (VTE)

Physicians frequently order a Free Protein S test when a patient presents with an unexplained deep vein thrombosis (DVT) or pulmonary embolism (PE), particularly at a relatively young age (under 50 years). Unprovoked clots—those occurring without obvious risk factors like major surgery, prolonged immobilization, or trauma—strongly suggest an underlying hereditary thrombophilia. Identifying a Free Protein S deficiency helps clinicians determine the appropriate duration and intensity of anticoagulant therapy to prevent life-threatening recurrent thrombotic events.

Evaluation of Recurrent Miscarriages and Pregnancy Complications

Recurrent pregnancy loss (defined as two or more consecutive miscarriages) and severe obstetric complications such as preeclampsia, placental abruption, or unexplained intrauterine growth restriction (IUGR) are key indications for thrombophilia screening. A deficiency in Free Protein S can lead to microvascular thrombosis within the developing placental circulation, compromising fetal blood supply and leading to pregnancy loss. Testing helps guide the use of prophylactic low-molecular-weight heparin in subsequent pregnancies.

Screening for Hereditary Thrombophilia due to Family History

A strong family history of early-onset venous thromboembolism or documented hereditary thrombophilia (such as Protein S, Protein C, or Antithrombin deficiency) is a major clinical indication. If a first-degree relative has experienced a life-threatening clot or has been diagnosed with a genetic coagulation disorder, testing asymptomatic family members can provide vital risk-stratification data, allowing for proactive prophylaxis during high-risk periods like surgeries, long-haul flights, or pregnancy.

Assessment of Neonatal Purpura Fulminans

In extremely rare cases, infants are born with homozygous or compound heterozygous Protein S deficiency, resulting in a complete absence of functional Protein S. This presents shortly after birth as purpura fulminans—a severe, rapidly progressive, and life-threatening thrombotic disorder characterized by microvascular thrombosis, skin necrosis, and disseminated intravascular coagulation (DIC). Immediate testing of Free Protein S levels is critical for confirming this diagnosis and initiating emergency replacement therapy.

Monitoring and Differential Diagnosis of Acquired Deficiencies

The Free Protein S test is also utilized to evaluate acquired hypercoagulable states. Since Protein S is synthesized in the liver and requires Vitamin K for its functional activation, patients with severe hepatic impairment, cirrhosis, or Vitamin K deficiency often exhibit reduced Free Protein S levels. Additionally, inflammatory conditions, active systemic lupus erythematosus (SLE), and nephrotic syndrome (where proteins are lost in the urine) can lead to acquired deficiencies that require clinical differentiation from genetic disorders.

What Does a Free Protein S Test Detect?

The Free Protein S test at Chughtai Lab is highly sensitive and capable of detecting a wide range of physiological, genetic, and acquired conditions affecting the coagulation cascade. The test detects:

• Congenital Protein S Deficiency Type I: Characterized by a quantitative reduction in both total and free Protein S antigen levels, along with a corresponding decrease in functional activity.
• Congenital Protein S Deficiency Type II: A qualitative defect where total and free antigen levels remain normal, but the functional activity of the protein is significantly reduced.
• Congenital Protein S Deficiency Type III: Characterized by normal total Protein S antigen levels but a selective, marked reduction in Free Protein S antigen and functional activity.
• Acquired deficiency secondary to active, acute deep vein thrombosis (DVT) due to rapid consumption of regulatory proteins during clot formation.
• Acquired deficiency due to acute pulmonary embolism (PE).
• Acquired deficiency secondary to severe hepatic dysfunction, liver cirrhosis, or hepatitis, which impairs the liver’s synthetic capacity.
• Acquired deficiency resulting from Vitamin K deficiency, which prevents the gamma-carboxylation required for functional Protein S activity.
• Acquired deficiency induced by oral anticoagulant therapy (specifically Vitamin K antagonists like Warfarin).
• Acquired deficiency associated with disseminated intravascular coagulation (DIC), where widespread microvascular clotting consumes coagulation inhibitors.
• Acquired deficiency due to nephrotic syndrome, where low-molecular-weight proteins, including Free Protein S, are abnormally excreted in the urine.
• Physiological reduction associated with normal pregnancy, particularly during the second and third trimesters.
• Physiological reduction caused by the use of estrogen-containing oral contraceptive pills (OCPs).
• Physiological reduction associated with hormone replacement therapy (HRT) in postmenopausal women.
• Physiological reduction in neonates and infants due to developmental delay in hepatic synthesis of coagulation proteins.
• Acquired deficiency secondary to severe systemic infections, sepsis, or inflammatory bowel disease (IBD), where elevated C4b-binding protein (an acute-phase reactant) binds more Free Protein S.
• Acquired deficiency associated with autoimmune disorders, such as Systemic Lupus Erythematosus (SLE) or Antiphospholipid Syndrome (APS).
• Normal Free Protein S levels, ruling out primary or secondary Protein S deficiency as a cause for hypercoagulability.
• Elevated Free Protein S levels, which are generally not associated with thrombotic risk but can occasionally occur during acute-phase inflammatory responses.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, we understand that timely diagnostic results are critical for clinical decision-making, especially when evaluating patients with suspected thrombophilia or active thromboembolic risks. The Free Protein S test is processed using state-of-the-art automated coagulation analyzers that utilize advanced immunoturbidimetric technology to ensure both rapid processing and exceptional accuracy.

The typical turnaround time for the Free Protein S test at Chughtai Lab is 24 to 48 hours from the time of sample collection. Once the analysis is completed and verified by our consultant hematologists, patients receive an automated SMS notification. Reports can be accessed instantly online through the official Chughtai Lab patient portal, downloaded via the Chughtai Lab mobile application, or received directly on WhatsApp. Physical copies of the reports can also be collected from any of our convenient collection centers across Pakistan.

Free Protein S Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Free Protein S Antigen Level (Adult Male)	Within established reference range (typically 65% to 140%)	Decreased levels (suggestive of Type I or Type III deficiency, or acquired states)
Free Protein S Antigen Level (Adult Female)	Within established reference range (typically 55% to 130%)	Decreased levels (pregnancy, OCP use, or hereditary deficiency)
Total Protein S Antigen	Within normal reference limits	Decreased in Type I deficiency; Normal in Type II and Type III deficiency
Protein S Functional Activity	Normal functional cofactor activity	Decreased in all types (Type I, II, and III) of Protein S deficiency
Liver Synthetic Function (Correlation)	Normal liver enzymes and albumin	Decreased Free Protein S with elevated liver enzymes (indicates hepatic synthesis failure)
Vitamin K Status (Correlation)	Normal PT/INR and coagulation profile	Decreased Free Protein S with prolonged PT/INR (indicates Vitamin K deficiency or Warfarin use)
Renal Protein Excretion (Correlation)	No significant proteinuria	Decreased Free Protein S with severe proteinuria (indicates nephrotic syndrome-induced loss)
Inflammatory Markers (Correlation)	Normal CRP and ESR	Decreased Free Protein S with highly elevated CRP (indicates acute-phase reaction increasing C4bBP binding)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Free Protein S?

• ISO 15189 Certified Laboratory: Chughtai Lab maintains international standards of quality and competence in medical laboratories, ensuring highly reliable diagnostic testing.
• Expert Consultant Pathologists: All specialized coagulation profiles, including Free Protein S, are supervised and interpreted by highly qualified consultant hematologists and pathologists.
• Advanced Coagulation Technology: The laboratory utilizes state-of-the-art, fully automated coagulation analyzers that minimize human error and deliver precise quantitative measurements.
• Convenient Home Sample Collection: Patients can easily schedule a professional phlebotomist to collect blood samples from the comfort of their homes across Pakistan.
• Rapid Digital Report Access: Reports are made available online, via a dedicated mobile app, and through WhatsApp, allowing patients and physicians to access results instantly.
• Strict Quality Control Protocols: Participation in rigorous internal quality control and external quality assurance schemes (EQAS) guarantees the accuracy of every test result.
• Extensive National Network: With hundreds of collection centers across Lahore, Karachi, Islamabad, and other major cities, Chughtai Lab offers unmatched accessibility.
• Patient-Centric Care: Dedicated support staff and comfortable, hygienic environments at all diagnostic centers ensure a seamless and stress-free patient experience.